- Report
- February 2024
Canada
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Bulgaria
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Brazil
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Bolivia
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Belgium
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Belarus
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Bangladesh
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Bahrain
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Austria
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Australia
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Argentina
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
United States
From €3501EUR$3,850USD£3,000GBP
- Report
- February 2024
United Kingdom
From €3183EUR$3,500USD£2,727GBP
- Report
- February 2024
Spain
From €3183EUR$3,500USD£2,727GBP
- Report
- February 2024
Japan
From €3183EUR$3,500USD£2,727GBP
- Report
- February 2024
Italy
From €3183EUR$3,500USD£2,727GBP
- Report
- February 2024
Serbia
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Russia
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Romania
From €2592EUR$2,850USD£2,221GBP
- Report
- February 2024
Qatar
From €2592EUR$2,850USD£2,221GBP

The CA 15 3 CA 27 29 Test is an in vitro diagnostic test used to measure the levels of two proteins, CA 15 3 and CA 27 29, in the blood. These proteins are associated with certain types of cancer, such as breast cancer, and can be used to monitor the progression of the disease. The test is typically used in conjunction with other tests, such as mammograms and ultrasounds, to provide a more comprehensive picture of the patient's health.
The CA 15 3 CA 27 29 Test market is composed of a variety of companies that specialize in the development and production of in vitro diagnostic tests. These companies include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Becton Dickinson. They offer a range of products, from basic tests to more advanced ones, to meet the needs of different healthcare providers. Show Less Read more